振德医疗用品股份有限公司 总经理工作细则 （2025 年 7 月修订） 第一章 总则 第一条 为进一步完善振德医疗用品股份有限公司（以下简称"公司"）的 公司治理结构，明确总经理职责、权限，根据《中华人民共和国公司法》（以下 简称"《公司法》"）等法律、法规、规章、规范性文件及《振德医疗用品股份 有限公司章程》（以下简称"《公司章程》"）的有关规定，制定本工作细则。 第三条 公司设总经理一名，由董事会聘任或解聘。 第四条 具有下列情形之一的人员，不得担任公司总经理： （一）具有《公司法》规定不得担任公司董事、高级管理人员情形的人员； （二）在公司控股股东、实际控制人及其控制的其他企业担任除董事、监事以外 其他职务的人员； （三）被中国证监会采取证券市场禁入措施，期限尚未届满的人员； （四）被证券交易所公开认定不适合担任上市公司董事和高级管理人员的人员； （五）最近三年内受到证券交易所公开谴责的人员； 第二条 总经理主持公司日常经营和管理工作，组织实施董事会决议，对董 事会负责。 第二章 总经理的任职资格和任免 （六）因涉嫌犯罪被司法机关立案侦查或者涉嫌违法违规被中国证监会立案调查， 尚未有明确结论意见的人员。 ...

Core Viewpoint - The document outlines the internal reporting system for significant information at Zhengde Medical Supplies Co., Ltd, ensuring timely, accurate, and complete disclosure of information that may impact the company's operations and investor decisions [1][2]. Group 1: General Principles - The purpose of the internal reporting system is to standardize the disclosure of significant information, ensuring effective communication and management within the company [1]. - Significant information includes events that could substantially affect the company's brand, operations, securities trading prices, and investor decisions, such as important meetings, major transactions, and significant risks [1][2]. Group 2: Reporting Obligations - "Internal reporting of significant information" requires designated personnel to promptly report relevant information to the board of directors when significant events occur [2]. - The individuals responsible for reporting include directors, senior management, department heads, and major shareholders, who must ensure the accuracy and completeness of the information reported [2][5]. Group 3: Scope of Significant Information - Significant information encompasses various categories, including important meetings, major transactions, related party transactions, significant litigation, and major risks [2][3]. - Specific thresholds for reporting major transactions include asset totals exceeding 10% of the company's audited total assets or net assets, and transaction amounts exceeding 10% of the company's audited net profit [3][4]. Group 4: Reporting Procedures - Information must be reported in writing through the company secretary, and urgent matters can be communicated via phone or email [15][16]. - The reporting process requires that information be reviewed and signed off by relevant department heads before submission to the board secretary [17]. Group 5: Responsibilities and Accountability - The chairman of the board is ultimately responsible for external information disclosure, while the board secretary manages the disclosure process and communication with stakeholders [23][24]. - Failure to comply with reporting obligations can lead to disciplinary actions, including potential legal consequences for individuals responsible for the oversight [31][32].

Core Points - The article outlines the implementation rules for cumulative voting at the shareholders' meeting of ZhenDe Medical Supplies Co., Ltd, aimed at protecting the interests of minority shareholders and improving corporate governance [1][2] - Cumulative voting allows shareholders to allocate their voting rights in a flexible manner, enabling them to concentrate votes on specific candidates [1][2] - The rules specify the nomination process for board candidates, including requirements for personal information and qualifications [2][3] Group 1 - The cumulative voting system grants each shareholder a number of votes equal to the number of shares held multiplied by the number of directors to be elected [1][2] - The rules state that cumulative voting must be used when electing or replacing two or more directors, while it is optional for single director elections [2][3] - Candidates for the board must provide detailed personal information and commit to fulfilling their duties if elected [3][4] Group 2 - The voting process for cumulative voting is defined, including how votes are calculated and the requirement for a majority to elect directors [4][5] - In cases where candidates receive the same number of votes, a second round of voting will be conducted to determine the elected directors [5] - The implementation rules can be revised by the board of directors based on legal requirements and company circumstances, and they take effect upon approval by the shareholders' meeting [5]

第一条 为规范振德医疗用品股份有限公司（以下简称"公司"、"振德医 疗"）第一期员工持股计划的实施，根据《中华人民共和国公司法》（以下简称 "《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《中国证监会关于上市公司实施员工持股计划试点的指导意见》 （以下简称"《指 导意见》"）等相关法律、法规、规范性文件和《公司章程》、《振德医疗用品 股份有限公司第一期员工持股计划（草案）》（以下简称"本员工持股计划"或 "本计划"）之规定，特制定本员工持股计划管理办法。 （修订稿） 第一章 总则 振德医疗用品股份有限公司 第一期员工持股计划管理办法 第二章 员工持股计划的制定 第二条 员工持股计划的目的 公司依据《公司法》、《证券法》、《指导意见》、《信息披露工作指引》 等有关法律、行政法规、规章、规范性文件和《公司章程》的规定，制定了本计 划草案。 公司员工自愿、合法、合规地参与本员工持股计划，持有公司股票的目的在 于建立和完善员工、股东的利益共享机制，改善公司治理水平，提高职工的凝聚 力和公司竞争力，调动员工的积极性和创造性，促进公司长期、持续、健康发展。 第三条 员工持股计划的基本原则 （一）依 ...

振德医疗用品股份有限公司 董事离职管理制度 （2025 年 7 月制定） 第一章 总则 第一条 为规范振德医疗用品股份有限公司（以下简称"公司"、"本公司"） 董事离职程序，确保公司治理结构的稳定性和连续性，维护公司及全体股东的合 法权益，公司根据《中华人民共和国公司法》 （以下简称" 《公司法》"）、 《中华人 民共和国证券法》 （以下简称"《证券法》"）、 《上海证券交易所股票上市规则》等 法律、法规和规范性文件以及《公司章程》的有关规定，结合公司实际情况，制 定本制度。 第二条 本制度适用于公司董事（含独立董事）因任期届满、辞职、被解除 职务或其他原因离职的情形。 第三条 公司董事离职管理应遵循以下原则： （一）合法合规原则：严格遵守国家法律法规、监管规定及《公司章程》的 要求； （二）公开透明原则：及时、准确、完整地披露董事离职相关信息； （三）平稳过渡原则：确保董事离职不影响公司正常经营和治理结构的稳定 性； （四）保护股东权益原则：维护公司及全体股东的合法权益。 第二章 离职情形与程序 第四条 公司董事离职包含任期届满未连任、主动辞职、被解除职务以及其 他导致董事实际离职等情形。 第五条 辞职程序 ...

第三条 本制度所称内部控制，是指公司董事会、高级管理人员及其他有关 人员为实现下列目标而提供合理保证的过程： (一)遵守国家法律、行政法规、部门规章及其他相关规定； 振德医疗用品股份有限公司 内部审计制度 （2025 年 7 月制定） 第一章 总则 第一条 为加强振德医疗用品股份有限公司（以下简称"公司"）内部审计工 作，提高内部审计的质量，根据《中华人民共和国审计法》、《中华人民共和国国 家审计准则》《企业内部控制基本规范》《上海证券交易所股票上市规则》等有关 法律、法规和规范性文件以及《公司章程》的有关规定，结合公司实际情况，制 定本制度。 第二条 本制度所称内部审计是指公司内部审计机构或人员，对其内部控制 和风险管理的有效性、财务信息的真实性和完整性以及经营活动的效率和效果等 开展的一种评价活动。 (二)提高公司经营的效率和效果； (三)保障公司资产的安全。 第四条 内部审计遵循"独立、客观、公正"的原则，保证其工作合法、合 理有效，完善公司内部约束机制，加强内部管理，提高公司经济效益。 第五条 公司董事会对内部控制制度的建立健全和有效实施负责，重要的内 部控制制度应当经董事会审议通过。 公司董事、高级 ...

Core Points - The article outlines the compensation management system for directors and senior management of Zhengde Medical Supplies Co., Ltd, aiming to establish an effective incentive and restraint mechanism to enhance operational efficiency [1][8] - The compensation management system is based on principles that align compensation structure with long-term company interests, correlate compensation levels with company size and performance, and match compensation with job responsibilities and individual performance [1][3] Summary by Sections General Principles - The system is designed to motivate directors and senior management, ensuring their work aligns with the company's long-term goals [1] - It applies to directors elected by the shareholders and senior management appointed by the board [1] Management Structure - The shareholders' meeting is responsible for reviewing the compensation plans for directors, while the board of directors reviews those for senior management [4] - The compensation and assessment committee of the board is tasked with establishing assessment standards and conducting annual evaluations [4][2] Compensation Composition - Independent directors and non-independent directors not holding other positions in the company receive a fixed director allowance, with no additional compensation or benefits [3] - Non-independent directors holding other positions receive compensation based on their role without additional director allowances [3] - Non-independent directors who are also senior management have a salary structure consisting of a base salary and performance bonuses linked to annual performance targets [3] Compensation Management and Distribution - Compensation is calculated based on actual tenure and performance for directors and senior management who change positions [4] - Directors and senior management, except for independent directors, are required to contribute to social insurance and housing funds [4] Salary Adjustment - The compensation system should support the company's strategic development and can be adjusted based on company performance and external conditions [7] - The board can approve temporary special rewards or penalties for specific matters as supplementary compensation [7] Supplementary Provisions - Any matters not covered by the system or inconsistent with relevant laws or company regulations will follow those regulations [8] - The board is responsible for interpreting the system, which takes effect upon approval by the shareholders' meeting [8]

振德医疗用品股份有限公司 内幕信息知情人登记管理制度 （2025 年 7 月修订） 第一章 总则 第一条 为规范振德医疗用品股份有限公司（以下简称"公司"）的内幕信 息管理，做好内幕信息保密工作，确保信息披露的"公开、公平、公正"原则， 有效防范内幕交易等证券违法违规行为，维护广大投资者的合法权益，根据《中 华人民共和国公司法》、《中华人民共和国证券法》、《上市公司信息披露管理办法》 《上市公司监管指引第 5 号——上市公司内幕信息知情人登记管理制度》《上海 证券交易所股票上市规则》和《公司章程》等有关规定，制定本制度。 第二条 公司董事会负责内幕信息及内幕信息知情人的管理工作，保证内幕 信息知情人档案真实、准确和完整，并按照有关法规要求及时报送。董事长为主 要责任人，董事会秘书负责组织协调公司内幕信息管理工作、办理公司内幕信息 知情人的登记入档及报送事宜。董事长与董事会秘书应当对内幕信息知情人档案 的真实、准确和完整签署书面确认意见。。董事会办公室协助董事会秘书做好公 司内幕信息的管理、登记、披露及备案的日常工作。公司审计委员会应当对内幕 信息知情人登记管理制度实施情况进行监督。 第三条 未经董事会批准同意 ...

Core Viewpoint - The article outlines the regulations and procedures for the selection and appointment of accounting firms by Zhengde Medical Supplies Co., Ltd, emphasizing the importance of maintaining audit quality and protecting shareholder interests [1][2]. Group 1: General Principles - The selection of accounting firms must comply with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [1]. - The appointment of accounting firms requires approval from the audit committee, board of directors, and shareholders' meeting [1][2]. - The controlling shareholders and actual controllers are prohibited from designating accounting firms or interfering with the independent review process [1]. Group 2: Quality Requirements for Accounting Firms - Selected accounting firms must possess independent legal status and meet qualifications set by regulatory authorities [2]. - Firms must have a fixed workplace, sound organizational structure, and robust internal management systems [2]. - The firms should have a good reputation and a record of quality, with no criminal penalties related to securities and futures business in the last three years [2]. Group 3: Selection Procedures - The audit committee is responsible for proposing the selection of accounting firms and overseeing the audit process [2][3]. - Various methods such as competitive negotiation, public bidding, and invitation bidding should be employed to ensure fairness in the selection process [4][5]. - The selection process must include a detailed evaluation of the firms based on criteria such as audit fees, qualifications, and quality management [6][7]. Group 4: Evaluation and Reporting - The audit committee must evaluate the performance of the appointed accounting firms annually and report to the board of directors [3][6]. - The evaluation criteria should include audit fee quotes, quality management levels, and risk management capabilities [6][7]. - Any significant changes in audit fees must be disclosed, especially if they exceed a 20% change from the previous year [8]. Group 5: Reappointment and Replacement Procedures - The audit committee must conduct a thorough evaluation before reappointing an accounting firm for the next year [9]. - Specific conditions warranting the replacement of an accounting firm include significant quality defects or delays in audit work [9][10]. - If a firm is replaced during the annual audit period, a temporary appointment must be made, subject to shareholder approval [9][10]. Group 6: Supervision and Penalties - The audit committee must remain vigilant regarding any irregularities in the selection and appointment of accounting firms [28]. - Serious violations by accounting firms can lead to penalties, including dismissal and financial liability for responsible individuals [29][30]. - Both the company and the accounting firms must prioritize information security and comply with relevant laws and regulations [31].

General Principles - The company establishes an information disclosure management system to regulate its disclosure behavior and protect investors' rights, in accordance with relevant laws and regulations [1][2] - Information disclosure refers to significant information that may impact the company's stock price and must be disclosed to the public and regulatory authorities in a timely manner [1][2] Disclosure Obligations - Disclosure obligors include the company, its directors, senior management, shareholders, and other relevant parties involved in significant transactions or changes [2] - Information disclosed must be timely, truthful, accurate, complete, and clear, without misleading statements or omissions [2][3] Disclosure Principles - Information must be disclosed simultaneously to all investors, and no advance disclosure is allowed except as required by law [2][3] - Insider information must not be disclosed or used for trading before it is legally disclosed [2][3] Reporting Requirements - The company must disclose periodic reports, including annual, semi-annual, and quarterly reports, which must be audited as per regulations [4][5] - The annual report must be disclosed within four months after the fiscal year-end, while semi-annual and quarterly reports have respective deadlines of two months and one month [5][6] Temporary Reports - The company must immediately disclose significant events that may impact stock prices, including changes in management, major contracts, or financial difficulties [8][9] - Any major changes in the company's operations or financial status must be reported promptly [9][10] Management of Disclosure - The board of directors and senior management are responsible for ensuring timely and accurate disclosures [12][13] - The company must maintain a record of disclosure activities and ensure compliance with internal controls [17][18] Media and Communication - The company’s designated media for disclosures include specific newspapers and the Shanghai Stock Exchange website [18] - Any promotional materials must not contain undisclosed significant information [18][19] Confidentiality and Penalties - Individuals with knowledge of undisclosed information are required to maintain confidentiality and may face penalties for unauthorized disclosures [19][19] - The company reserves the right to pursue legal action against those who disclose information improperly [19]